222 related articles for article (PubMed ID: 6291391)
1. Comparison of pharmacodynamic properties of various estrogen formulations.
Mashchak CA; Lobo RA; Dozono-Takano R; Eggena P; Nakamura RM; Brenner PF; Mishell DR
Am J Obstet Gynecol; 1982 Nov; 144(5):511-8. PubMed ID: 6291391
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
3. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
[TBL] [Abstract][Full Text] [Related]
4. Biologic effects of delta-8-estrone sulfate in postmenopausal women.
Bhavnani BR; Cecutti A; Dey MS
J Soc Gynecol Investig; 1998; 5(3):156-60. PubMed ID: 9614646
[TBL] [Abstract][Full Text] [Related]
5. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male.
Lübbert H; Leo-Rossberg I; Hammerstein J
Fertil Steril; 1992 Sep; 58(3):603-8. PubMed ID: 1387850
[TBL] [Abstract][Full Text] [Related]
6. Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
Varma TR; Everard D; Hole D
Acta Obstet Gynecol Scand; 1985; 64(2):105-9. PubMed ID: 2984875
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Sipinen S; Lähteenmäki P; Luukkainen T
Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
[TBL] [Abstract][Full Text] [Related]
10. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
[TBL] [Abstract][Full Text] [Related]
11. Suppression of urinary and plasma follicle-stimulating hormone by exogenous estrogens in prepubertal and pubertal children.
Kelch RP; Kaplan SL; Ghumbach MM
J Clin Invest; 1973 May; 52(5):1122-8. PubMed ID: 4700487
[TBL] [Abstract][Full Text] [Related]
12. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236
[TBL] [Abstract][Full Text] [Related]
13. Biologic effects of transdermal estradiol.
Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
[TBL] [Abstract][Full Text] [Related]
14. Autocrine role of estrogens in the augmentation of luteinizing hormone receptor formation in cultured rat granulosa cells.
Kessel B; Liu YX; Jia XC; Hsueh AJ
Biol Reprod; 1985 Jun; 32(5):1038-50. PubMed ID: 2990583
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Englund DE; Johansson ED
Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral estrogen therapy on serum FSH and LH levels in young women with hyper-gonadotrophic ovarian failure.
Leis D; Braun S
Arch Gynecol; 1981; 230(3):225-30. PubMed ID: 6264865
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropins and prolactin during estrogen replacement therapy.
Helgason S; Carlström K; Damber MG; von Schoultz B
Acta Obstet Gynecol Scand; 1981; 60(5):515-6. PubMed ID: 6795895
[No Abstract] [Full Text] [Related]
[Next] [New Search]